- Home
- DCOM vs BHVN Comparison
DCOM vs BHVN Comparison
Compare DCOM & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DCOM | BHVN |
|---|---|---|
| Founded | 1864 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.1B |
| IPO Year | 1996 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DCOM | BHVN |
|---|---|---|
| Price | $42.80 | $15.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 17 |
| Target Price | ★ $47.80 | $23.33 |
| AVG Volume (30 Days) | 396.4K | ★ 3.0M |
| Earning Date | 10-20-2026 | 10-29-2026 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | ★ 329.09 | 26.08 |
| EPS | ★ 2.40 | N/A |
| Revenue | ★ $19,907,000.00 | N/A |
| Revenue This Year | $16.16 | N/A |
| Revenue Next Year | $14.21 | N/A |
| P/E Ratio | $28.04 | ★ N/A |
| Revenue Growth | ★ 19.03 | N/A |
| 52 Week Low | $25.63 | $7.48 |
| 52 Week High | $43.38 | $18.24 |
Technical Indicators
Market Signals| Indicator | DCOM | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 64.03 | 60.75 |
| Support Level | $39.64 | $13.15 |
| Resistance Level | $43.38 | $16.85 |
| Average True Range (ATR) | 1.06 | 1.00 |
| MACD | 0.28 | 0.44 |
| Stochastic Oscillator | 89.18 | 79.11 |
Price Performance
Historical ComparisonAbout DCOM Dime Community Bancshares Inc.
Dime Commercial Bancshares Inc is the holding company for Dime Commercial Bank, a New York State-chartered trust company with approximately $15 billion in assets and the number one deposit market share on Greater Long Island.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.